Hello and welcome to my Nuzzel newsletter!
I'm Ronny, International Neuroendocrine Cancer Advocate. Independent Patient Voice. Award winning WEGO Health Patient Leader, Cure Today Contributor, Featured 1 million + Blogger, Veteran.
– Apr 22, 2015, 11:20 AM
There's a constant debate regarding the validity of the term ‘ Carcinoid ‘. I've posted about this a few times and as far as I know, the debate has been raging for some years. Although the issue is potentially complex, there is one…
Share this with Email Share this with Facebook Share this with Twitter Share this with Whatsapp The number of men dying from prostate cancer has overtaken female deaths from breast cancer for the first time in the UK, figures show. An ageing…
NO WONDER they are called “patients”. When people enter the health-care systems of rich countries today, they know what they will get: prodding doctors, endless tests, baffling jargon, rising costs and, above all, long waits. Some…
– Feb 1, 2018, 8:52 AM
FDA finally approves PRRT in USA. Long awaited and has caused much excitement on all forms of social media. I'm very pleased for my USA friends but we mustn't forget it's also required in so many other places. Help me populate locations in my live…
Description: Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center joins us at MOASC's Spotlight On Hematology in Huntington Beach to discuss the effective oral drugs to use (Rivaroxaban, Apixaban, Edoxaban) if one has cancer or clots.
– Jan 10, 2018, 11:32 AM
RadioMedix Inc. and AREVA Med today announced the initiation in the United States of Phase 1 trial for AlphaMedix in patients with somatostatin receptor (SSTR) positive Neuroendocrine Tumors (NETs). AlphaMedix is composed of a somatostatin analogue…